Ensign Peak Advisors
IMA

Ensign Peak Advisors’s ImageneBio Inc IMA Stock Holding History

Ensign Peak Advisors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,150
Closed -$19.6K – 1724
2024
Q1 		$19.6K Sell
1,150
-6,376
-85% -$116K ﹤0.01% 1723
2023
Q4 		$178K Hold
7,526
– – ﹤0.01% 1724
2023
Q3 		$391K Hold
7,526
– – ﹤0.01% 1649
2023
Q2 		$592K Hold
7,526
– – ﹤0.01% 1580
2023
Q1 		$312K Hold
7,526
– – ﹤0.01% 1711
2022
Q4 		$240K Hold
7,526
– – ﹤0.01% 1731
2022
Q3 		$321K Hold
7,526
– – ﹤0.01% 1676
2022
Q2 		$400K Sell
7,526
-3,125
-29% -$172K ﹤0.01% 1557
2022
Q1 		$780K Hold
10,651
– – ﹤0.01% 1343
2021
Q4 		$1.6M Buy
10,651
+2,318
+28% +$376K ﹤0.01% 1052
2021
Q3 		$1.26M Hold
8,333
– – ﹤0.01% 1339
2021
Q2 		$1.41M Hold
8,333
– – ﹤0.01% 1305
2021
Q1 		$2.83M Buy
+8,333
New +$2.85M 0.01% 901

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors's IMA Position: Q2 2024 in Review

Ensign Peak Advisors sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 1,150 shares — an estimated $19.6K sold.

Ensign Peak Advisors first reported a position in IMA in Q1 2021 and held it in 13 quarters. The position peaked at $2.83M in Q1 2021. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Ensign Peak Advisors reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,150 ImageneBio Inc shares in Q2 2024, an estimated $19.6K.
  • Ensign Peak Advisors first reported a position in ImageneBio Inc in Q1 2021 and held it in 13 quarters.
  • Ensign Peak Advisors's ImageneBio Inc position peaked at $2.83M in Q1 2021.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.